Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sertraline-based algorithm for MDD in Brazilian Public Health
NCT02901249Phase 4Completed
- Sponsor
- Universidade Federal do Rio Grande do Sul
- Start
- May 2010
- Primary completion
- Nov 2014
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of sertraline in major depressive disorder (MDD), sponsored by Universidade Federal do Rio Grande do Sul. Primary endpoint: Number of Participants With Response to Treatment at 8 weeks. Started May 2010; status: completed.
02
Drugs
sertraline
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02901249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02901249.